Behçet’s Disease in Patients of German and Turkish Origin — A Comparative Study

  • Ina Kötter
  • Reinhard Vonthein
  • Ilhan Günaydin
  • Claudia Müller
  • Lothar Kanz
  • Manfred Zierhut
  • Nicole Stübiger
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)


Ocular Involvement International Study Group Ocular Manifestation Tissue Antigen German Registry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Verity, D.H., Marr, J.E., Ohno, S., et al., 1999, Behçet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54: 213–220.PubMedGoogle Scholar
  2. 2.
    Chang, H.K., and Cheon, K.S., 2002, The clinical significance of a pathergy reaction in patients with Behçet’s disease. J. Kor. Med. Sci. 17: 371–374.Google Scholar
  3. 3.
    Yazici, H., Chamberlain, M.A., Tuzun, Y., et al., 1984, A comparative study of the pathergy reaction among Turkish and British patients with Behçet’s disease. Ann. Rheum. Dis. 43: 74–75.PubMedGoogle Scholar
  4. 4.
    Zouboulis, Ch.C., 1999, Epidemiology of Adamantiades-Behçet’s disease. Ann. Med. Interne (Paris) 150: 488–498.Google Scholar
  5. 5.
    O’Neill, T., Rigby, A., McHugh, S., et al., 1993, Regional differences in clinical manifestations of Behçet’s disease. In Behçet’s disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 159–163.Google Scholar
  6. 6.
    Krause, I., Mader, R., Sulkes, J., et al., 2001, Behçet’s disease in Israel: the influence of ethnic origin on disease expression and severity. J. Rheumatol. 28: 1033–1036.PubMedGoogle Scholar
  7. 7.
    Muhaya, M., Lightman, S., Ikeda, E., et al., 2000, Behçet’s disease in Japan and in Great Britain: a comparative study. Ocul. Immunol, Inflamm. 8: 141–148.Google Scholar
  8. 8.
    International Study Group for Behçet’s disease, 1990, Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078–1080.Google Scholar
  9. 9.
    Zouboulis, Ch.C., Kötter, I., Djawari, D., et al., 1997, Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med. J. 38: 411–422.PubMedGoogle Scholar
  10. 10.
    Yurdakul, S., Günaydin, I., Tüzün, Y., et al., 1998, The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J. Rheumatol. 15: 820–822.Google Scholar
  11. 11.
    Tüzün, Y., Yurdakul, S., Cem Mat, M., et al., 1996, Epidemiology of Behçet’s syndrome in Turkey. Int. J. Dermatol. 35: 618–620.PubMedGoogle Scholar
  12. 12.
    Yazici, H., Yurdakul, S., and Hamuryudan, V., 2001, Behçet’s disease. Curr. Opin. Rheumatol. 13: 18–22.PubMedGoogle Scholar
  13. 13.
    Davies, P.G., Fordham, J.N., Kirwan, J.R., et al., The pathergy test and Behçet’s syndrome in Britain. Ann. Rheum. Dis. 43: 70–73.Google Scholar
  14. 14.
    Gürler, A., Boyvat, A., and Türsen, U., 1997, Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med. J. 38: 423–427.PubMedGoogle Scholar
  15. 15.
    Tüzün, Y., Yazici, H., Pazarli, H., et al., 1979, The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behçet’s disease in Turkey. Acta Derm. Venereol. (Stockholm) 59: 77–79.Google Scholar
  16. 16.
    Özarmagan, G., Saylan, T., Azizlerli, G., et al., 1991, Re-evaluation of the pathergy test in Behçet’s disease. Acta Derm. Venereol. (Stockholm) 71: 75–76.Google Scholar
  17. 17.
    Kötter, I., Günaydin, I., Stübiger, N., et al., 2001, Comparative analysis of the association of HLA-B*51 suballeles with Behçet’s disease in patients of German and Turkish origin. Tissue Antigens 58: 166–170.PubMedGoogle Scholar
  18. 18.
    Mizuki, N., Ota, M., Katsuyama, Y., et al., 2002, Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and-B*5108 with Behçet’s disease in Greek patients. Tissue Antigens 59: 118–121.CrossRefPubMedGoogle Scholar
  19. 19.
    Ghayad, E., and Tohme, A., 1995, Behçet’s disease in Lebanon: report of 100 cases. J. Med. Liban. 43: 2–7.PubMedGoogle Scholar
  20. 20.
    Müftüoglu, A.U., Yazici, H., Yurdakul, S., et al., 1981, Behçet’s disease: lack of correlation of clinical manifestations with HLA antigens. Tissue Antigens 17: 226–230.PubMedGoogle Scholar
  21. 21.
    Yazici, H., Chamberlain, M.A., Schreuder, G.M., et al., 1983, HLA B5 and Behçet’s disease. Ann. Rheum. Dis. 42: 602–603.PubMedGoogle Scholar
  22. 22.
    Gül, A., Uyar, F.A., Inanc, M., et al., 2001, Lack of association of HLA-B*51 with a severe disease course in Behçet’s disease. Rheumatology (Oxford) 40: 668–672.Google Scholar
  23. 23.
    Azizleri, G., Aksungur, V.L., Sarica, R., et al., 1994, The association of HLA-B5 antigen with specific manifestations of Behçet’s disease. Dermatology 188: 293–295.PubMedGoogle Scholar
  24. 24.
    Yazici, H., Biyikili, S., van der Linden, S.M., et al., 2001, The “zero patient” design to compare the prevalences of rare diseases. Rheumatology (Oxford) 40: 121–122.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Ina Kötter
    • 2
  • Reinhard Vonthein
    • 3
  • Ilhan Günaydin
    • 2
  • Claudia Müller
    • 1
  • Lothar Kanz
    • 2
  • Manfred Zierhut
    • 4
  • Nicole Stübiger
    • 4
  1. 1.Section of Transplantation Immunology and ImmunohaematologyUniversity HospitalTübingenGermany
  2. 2.Department of Internal Medicine II (Hematology, Oncology, Immunology, RheumatologyUniversity HospitalTübingenGermany
  3. 3.Department of Medical BiometryUniversity HospitalTübingenGermany
  4. 4.Department of Ophthalmology IIUniversity HospitalTübingenGermany

Personalised recommendations